The global hernia mesh device market is on a steady growth trajectory, with its valuation expected to surge from USD 5.63 billion in 2024 to USD 11.01 billion by 2034, growing at a CAGR of 6.94% between 2025 and 2034. A combination of technological advancements, rising hernia incidences, and expanding surgical procedures is fueling this growth.
North America led the market in 2024, while Asia-Pacific is anticipated to be the fastest-growing region with a CAGR exceeding 13%. Among mesh types, synthetic mesh dominated the market in 2024.
This article dives into the top hernia mesh device companies driving this market, exploring their background, product portfolios, and financial strength.
About: A global medical technology giant headquartered in the U.S., BD specializes in advanced surgical and interventional solutions.
Products: Offers Phasix™ mesh, Ventralight™ ST mesh for hernia repair.
Market Cap: Approx. USD 70+ billion.
About: One of the world’s largest medical device companies, headquartered in Ireland.
Products: Parietex™ mesh portfolio; Symbotex™, ProGrip™, and others.
Market Cap: Approx. USD 105 billion.
About: A privately held U.S. company known for its innovative medical devices and GORE-TEX® materials.
Products: GORE® DualMesh®, Synecor™ Preperitoneal Biomaterial.
Market Cap: Estimated USD 3+ billion (privately held).
About: German-based healthcare and pharma company offering surgical and infusion therapy solutions.
Products: Premilene® Mesh, Optilene® Mesh Elastic.
Market Cap: Estimated USD 8–10 billion (private entity).
About: Through its Ethicon division, J&J is a pioneer in surgical technologies.
Products: PROLENE®, ULTRAPRO®, and PHYSIOMESH™.
Market Cap: USD 360+ billion (J&J total).
About: U.S.-based company delivering minimally invasive medical solutions globally.
Products: Biodesign® Hernia Graft.
Market Cap: Privately held; estimated in USD billions.
About: Subsidiary of Getinge Group; focuses on cardiovascular and hernia products.
Products: C-QUR™ Mesh with Omega-3 bioresorbable coating.
Market Cap: Parent company Getinge AB valued at approx. USD 5 billion.
About: Italian company specializing in hernia repair and prosthesis devices.
Products: Herniamesh LPS, Dualmesh, and T-Line Mesh.
Market Cap: Private SME.
About: U.S.-based company known for regenerative technologies and surgical devices.
Products: SurgiMend® PRS Mesh.
Market Cap: Approx. USD 4 billion.
About: Originally a tissue matrix developer, now part of AbbVie via Allergan acquisition.
Products: Strattice™ Reconstructive Tissue Matrix.
Market Cap: AbbVie’s total valuation exceeds USD 250 billion.
About: A leader in resorbable polymer technology used in medical applications.
Products: TephaFLEX® mesh based on P4HB polymer.
Market Cap: Acquired by Becton Dickinson.
About: Regenerative medicine company now part of Integra LifeSciences.
Products: MatriStem® Surgical Matrix for hernia repair.
Market Cap: Integrated under Integra LifeSciences’ umbrella.
About: Italy-based manufacturer specializing in surgical and diagnostic devices.
Products: Hernia meshes for laparoscopic and open surgeries.
Market Cap: Small to mid-sized privately held company.
About: Swedish company focused on absorbable mesh solutions for surgery.
Products: TIGR® Matrix Surgical Mesh.
Market Cap: Privately held.
About: French manufacturer of high-tech textile implants.
Products: UPTIA®, TiO2Mesh™.
Market Cap: Private SME in biotech sector.
About: Turkish company manufacturing mesh and surgical solutions.
Products: BetaMesh®, BetaPlug®.
Market Cap: Emerging regional player.
About: German-based innovator in textile implants and surgical meshes.
Products: FEG Soft Meshes, Composite Meshes.
Market Cap: Private firm.
About: U.S.-based company focused on value-added minimally invasive surgical products.
Products: Freedom® Ventral Hernia Repair Systems.
Market Cap: Private, niche innovator.
About: Covidien was acquired by Medtronic in 2015.
Products: Developed Parietex™ Composite Mesh.
Market Cap: Integrated into Medtronic.
Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com
Market Size (2024): USD 5.63 Billion
Market Size (2025): USD 6.02 Billion
Market Size (2034): USD 11.01 Billion
CAGR (2025–2034): 6.94%
Top Region: North America
Fastest Growing Region: Asia-Pacific (>13% CAGR)
Leading Mesh Type: Synthetic Mesh
1. What is driving the growth of the hernia mesh device market?
Rising incidence of hernias, growing elderly population, and advancements in surgical mesh technologies are key growth drivers.
2. Which company dominates the global hernia mesh device market?
Medtronic and Johnson & Johnson (Ethicon) are considered leaders due to broad product portfolios and global reach.
3. What types of hernia mesh are most in demand?
Synthetic mesh is the most widely used due to its strength, affordability, and compatibility.
4. Which region will grow fastest in the coming years?
Asia-Pacific is expected to see the highest growth due to expanding healthcare access and rising surgical volumes.
5. Are there any bioabsorbable hernia meshes available in the market?
Yes, companies like Novus Scientific (TIGR® Matrix) and Tepha Inc. offer resorbable mesh options.
Source : https://www.towardshealthcare.com/insights/hernia-mesh-device-market-sizing
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5893
The global digital health and wellness market is projected to expand from US$ 498.99 billion in 2024 to US$ 3,568.11… Read More
The global radiopharmaceutical market is projected to grow from USD 6.8 billion in 2024 to USD 14.11 billion by 2034,… Read More
The U.S. life science market is on an upward trajectory, poised to generate substantial revenue growth, potentially climbing into the… Read More
The U.S. cell therapy market size is forecast to grow at a CAGR of 21.46%, from USD 8.04 billion in… Read More
The global animal biotechnology market was USD 28.17 billion in 2024, rose to USD 30.97 billion in 2025, and is… Read More
The global ophthalmology devices market was US$ 7.51 billion in 2024, rose to US$ 7.89 billion in 2025, and is… Read More